CTXR earnings: a positive outcome, +13.3%

On August 11, 2022, Citius Pharmaceuticals, Inc. reached its earnings. The result was a positive outcome, and the stock moved +13.3% in the window around the event. It had already run +14.2% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.